ePoster

MULTIMODAL NON-PHARMACOLOGICAL INTERVENTIONS ATTENUATE TAU PROPAGATION IN R3M4 TAU TRANSGENIC MICE

Tomas Smolekand 3 co-authors

Institute of Neuroimmunology, SAS, v.v.i.

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS02-07PM-366

Presentation

Date TBA

Board: PS02-07PM-366

Poster preview

MULTIMODAL NON-PHARMACOLOGICAL INTERVENTIONS ATTENUATE TAU PROPAGATION IN R3M4 TAU TRANSGENIC MICE poster preview

Event Information

Poster Board

PS02-07PM-366

Abstract

The aim of this study was to investigate the mechanistic effects of multimodal non-pharmacological interventions on tau propagation and associated pathological processes in a preclinical mouse model of Alzheimer’s disease. R3m4 tau transgenic mice were inoculated with human tau isolates to induce tau propagation and subsequently subjected to a combined intervention consisting of environmental enrichment and dietary modulation. Neuropathological, molecular, and biochemical analyses were performed to assess tau pathology, neuroinflammatory responses, synaptic integrity, and alterations in energy metabolism. Multimodal non-pharmacological interventions significantly attenuated tau propagation and modulate neuroinflammation and homeostasis compared to control animals. These effects were accompanied by modulation of pathways implicated in synaptic plasticity, inflammatory signalling, and cellular energetics. Collectively, these findings demonstrate that combined lifestyle-related interventions effectively modulate tau-driven neurodegeneration and provide experimental support for multimodal non-pharmacological strategies in Alzheimer’s disease research.
Acknowledgement : This work was supported by JPND MULTI-MEMO, APVV -23-0420 and VEGA 2/0155/25 grants.

Recommended posters

TARGETING MICROGLIA TO MITIGATE TAU PATHOLOGY AND COGNITIVE DEFICITS IN A DOUBLE-TRANSGENIC APP-TAU MOUSE MODEL

Yixia Jin, Uxía Fraga-Bouzas, Irene Pallás, Carlos A. Saura, Mar Puigdellívol

CLOSED-LOOP SUPPRESSION OF EARLY NETWORK HYPEREXCITIBILITY FOR DEMENTIAS ASSOCIATED WITH TAUOPATHY

Benito Maffei, Chiara Dyson, Qinyao Weng, Zoe Windsor, Marco Leite, Eleni Thomas, Francisco Moreira, Nathaneal O'Neill, Rohan de Silva, Karen Duff, Dimitri Kullmann, Gabriele Lignani

EARLY- AND LATE-ONSET DIETARY INTERVENTIONS MODULATE COGNITIVE AND METABOLIC DYSFUNCTION IN A TDP-43 PROTEINOPATHY MOUSE MODEL

Karen Javaloyes García, Juan Miguel Godoy Corchuelo, Irene Jiménez Coca, Jesús Jiménez Rodríguez, Patricia Quesada Manzano, Silvia Corrochano Sánchez

DEVELOPMENT OF AN IN-VIVO MODEL OF TAUOPATHY THROUGH INTRA-HIPPOCAMPAL INJECTION OF HUMAN TAU PRE-FORMED FIBRILS INTO THE BRAINS OF AGED MICE

Georgia Culley, Grace Flower, Adrien Chabert, Alexis Heesen, Ludovic Ainardi, Carla Rocci, Alexandre Wojcinski, Alexandre Henriques, Noelle Callizot

A NOVEL INDUCIBLE MODEL TO STUDY TAUOPATHY IN ALZHEIMER’S DISEASE APPLICABLE TO BOTH, MOUSE AND HUMAN NEURAL TISSUES

Nerea Gomez Rivada, Marcos Galán Ganga, Elisa Marín Ordovas, Marta Cervera-Sospedra, Georgina Bombau, Sara Borràs Pernas, Manuel Comabella, Andrés Miguez, Josep M Canals, Albert Giralt

BEYOND AMYLOID AND TAU: AAV DELIVERY OF CELLULAR RESILIENCE ENHANCER PREVENTS COGNITIVE DECLINE IN ALZHEIMER’S DISEASE MOUSE MODEL

Kadri Seppa, Ritwick Sawarkar

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.